The results revealed that there were no significant differences in the levels of methylation, methyltransferase, or demethylase in the cerebellum samples from the two groups, which is consistent with the fact that the main pathogenic sites of AD are located in the cerebral cortex and the hippocampus. Here, MBD2 is linked to Alzheimer disease.